Natalizumab for moderate to severe Crohn's disease in clinical practice: The Mayo Clinic Rochester experience
Kane, S.V., Horst, S., Sandborn, W.J., Becker, B., Neis, B., Moscandrew, M., Hanson, K.A., Tremaine, W.J., Bruining, D.H., Faubion, W.A., Pardi, D.S., Harmsen, W.S., Zinsmeister, A.R., Loftus, E.V.
Published in Inflammatory bowel diseases (01.12.2012)
Published in Inflammatory bowel diseases (01.12.2012)
Get full text
Journal Article
Faecal microbiota transplantation for eradicating carriage of multidrug-resistant organisms: a systematic review
Saha, S., Tariq, R., Tosh, P.K., Pardi, D.S., Khanna, S.
Published in Clinical microbiology and infection (01.08.2019)
Published in Clinical microbiology and infection (01.08.2019)
Get full text
Journal Article